Literature DB >> 28041711

Bifurcation lesions involved in the recanalization process of coronary chronic total occlusions: Incidence, treatment and clinical implications.

Soledad Ojeda1, Manuel Pan2, Alejandro Gutiérrez3, Miguel Romero2, Jorge Chavarría2, Javier Suárez de Lezo2, Francisco Mazuelos2, Laura Pardo2, Francisco Hidalgo2, Francisco Carrasco2, José Segura2, Enrique Durán2, Carlos Ferreiro2, José J Sánchez2, Sara Rodríguez2, Jesús Oneto3, Jose Suárez de Lezo2.   

Abstract

BACKGROUND: The presence of a bifurcation (BL) in the context of a coronary chronic total occlusion (CTO) represents an additional difficulty. This study analyzes the incidence of BLs in CTO recanalization, the treatment, predictors of bifurcation technical success and their clinical impact. METHODS AND
RESULTS: BLs with a side branch (SB) ≥2.0mm located proximally, distally or within the occluded segment were observed in 130 (33%) of 391 CTO. Provisional stenting was the strategy more frequently used (94%). Bifurcation success (stenosis <30% in main vessel and TIMI flow III in both branches) was achieved in 105 patients (81%). In the remaining 25 (19%), the TIMI flow at the SB was <III. Predictors of bifurcation success were baseline SB wiring (OR 0.01, 95% CI: 0.001-0.09; p<0.01), the absence of dissection across the bifurcation (OR 0.10, 95% CI: 0.02-0.49; p<0.01) and non-true BLs (OR 0.16, 95% CI: 0.04-0.68; p<0.05). Regarding in-hospital results, patients with final TIMI flow <III at the SB had a higher incidence of periprocedural MI (32% vs 4.8%; p<0.01). Subsequently, the rate of MI was higher in patients with CTO-BLs than in those without BLs. At follow-up, there were no differences in the event rate between CTO-BLs and non CTO-BLs (7.7% vs 9.5%, p=ns)
CONCLUSIONS: BLs in CTO is a frequent finding and could be approached as regular bifurcations. The primary success was low and this was associated with a higher incidence of periprocedural MI. Baseline SB wiring was a powerful predictor of technical success.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bifurcation intervention; Chronic total coronary occlusion; Drug-eluting stent; Percutaneous coronary intervention

Mesh:

Year:  2016        PMID: 28041711     DOI: 10.1016/j.ijcard.2016.12.088

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  A New Occluding Balloon-Facilitated Reversed Guidewire Technique in Successful Percutaneous Coronary Intervention for the Right Coronary Artery Chronic Total Occlusion Involving Distal Bifurcation.

Authors:  Kuan-Liang Liu; Chi-Jen Chang
Journal:  Acta Cardiol Sin       Date:  2021-05       Impact factor: 2.672

Review 2.  Chronic Total Occlusion Interventions: Update on Current Tips and Tricks.

Authors:  Peter Tajti; Iosif Xenogiannis; Dimitris Karmpaliotis; Khaldoon Alaswad; Farouc A Jaffer; M Nicholas Burke; Imre Ungi; Emmanouil S Brilakis
Journal:  Curr Cardiol Rep       Date:  2018-10-22       Impact factor: 2.931

3.  Predictors and complications of side branch occlusion after recanalization of chronic total occlusions complicated with bifurcation lesions.

Authors:  Yunfei Guo; Hongyu Peng; Yejing Zhao; Jinghua Liu
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

4.  The importance of side branch preservation in the treatment of chronic total occlusions with bifurcation lesions.

Authors:  Yuya Adachi; Yoshihisa Kinoshita; Akira Murata; Yoshiaki Kawase; Munenori Okubo; Yoriyasu Suzuki; Tatsuya Ito; Hitoshi Matsuo; Takahiko Suzuki
Journal:  Int J Cardiol Heart Vasc       Date:  2021-09-16

Review 5.  Percutaneous Coronary Intervention in Chronic Total Occlusion.

Authors:  Luiz Fernando Ybarra; Marcelo J C Cantarelli; Viviana M G Lemke; Alexandre Schaan de Quadros
Journal:  Arq Bras Cardiol       Date:  2018-05       Impact factor: 2.000

6.  Revascularization of Coronary Artery Chronic Total Occlusion by Active Antegrade Reverse Wire Technique.

Authors:  Xiao-Jiao Zhang; Zhan-Xiu Zhang; Yong Wang; Pei-Pei Hou; Da-Ming Mu; Cheng-Fu Wang; De-Feng Luo; Bao-Jun Chen; Ai-Jie Hou; Bo Luan
Journal:  J Interv Cardiol       Date:  2021-02-10       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.